By drugs |
Blood Type Not Associated With COVID-19 Outcomes
All News Consumer Pro New Drugs Pipeline Clinical Trials FDA Alerts
FRIDAY, April 9, 2021 -- Blood type is not associated with COVID-19 susceptibility or outcomes, according to a research letter published online April 5 in JAMA Network Open.
Jeffrey L. Anderson, M.D., from Intermountain Medical Center Heart Institute in Salt Lake City, and colleagues assessed whether blood type is associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) susceptibility and COVID-19 severity. The analysis included 107,796 individuals who were tested for SARS-CoV-2 between March 3 and Nov. 2, 2020, at an integrated health care system of 24 hospitals and 215 clinics in Utah, Idaho, and Nevada.
The researchers found that blood type was not associated with disease susceptibility or severity, including viral positivity, hospitalization, or intensive care unit (ICU) admission. Type A was not associated with increased viral positivity (odds ratio, 0.97; 95 percent confidence interval, 0.93 to 1.01; P = 0.11), hospitalization (odds ratio, 0.89; 95 percent confidence interval, 0.80 to 0.99; P = 0.03), or ICU admission (odds ratio, 0.84; 95 percent confidence interval, 0.69 to 1.02; P = 0.08) compared with type O blood. Outcomes were no worse for types B or AB than for type O. Results were similar for analyses restricted to White patients.
"Given the large and prospective nature of our study and its strongly null results, we believe that important associations of SARS-CoV-2 and COVID-19 with ABO groups are unlikely and will not be useful factors associated with disease susceptibility or severity on either an individual or population level for similar environments and ancestries," the authors write.
One author disclosed financial ties to AstraZeneca and GlaxoSmithKline.
© 2021 HealthDay. All rights reserved.
Posted: April 2021
Further Support and Information on COVID-19COVID-19: Prevention & Investigational Treatments COVID-19 Support Group Coronavirus Disease Guide
Read this next
Physician's Briefing Weekly Coronavirus Roundup
Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of April 5 to 9, 2021. This roundup...
In-Hospital SARS-CoV-2 Mortality Declined Throughout Pandemic
FRIDAY, April 9, 2021 -- In-hospital mortality for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-positive patients of all ages has declined throughout the pandemic...
Supply of J&J COVID-19 Vaccine to Drop 86 Percent Next Week
FRIDAY, April 9, 2021 -- In a setback to a national vaccination campaign that was finally gaining ground, the federal government said Thursday that Johnson & Johnson will...>